HighTower Advisors LLC Reduces Stock Holdings in HealthEquity, Inc. $HQY

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

HighTower Advisors LLC trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 87,786 shares of the company's stock after selling 7,289 shares during the quarter. HighTower Advisors LLC owned approximately 0.10% of HealthEquity worth $7,758,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC raised its holdings in shares of HealthEquity by 24.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company's stock worth $564,000 after buying an additional 1,265 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its stake in HealthEquity by 7,983.6% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company's stock worth $2,179,000 after acquiring an additional 24,350 shares in the last quarter. GAMMA Investing LLC grew its stake in HealthEquity by 25.9% in the 1st quarter. GAMMA Investing LLC now owns 1,571 shares of the company's stock worth $139,000 after acquiring an additional 323 shares in the last quarter. WCM Investment Management LLC bought a new position in HealthEquity in the 1st quarter worth about $20,230,000. Finally, Oppenheimer Asset Management Inc. grew its stake in HealthEquity by 6.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 75,206 shares of the company's stock worth $6,646,000 after acquiring an additional 4,614 shares in the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Jon Kessler sold 134,183 shares of HealthEquity stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.08, for a total value of $15,039,230.64. Following the transaction, the director directly owned 253,510 shares in the company, valued at approximately $28,413,400.80. This trade represents a 34.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 1,794 shares of the business's stock in a transaction on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the transaction, the executive vice president owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is currently owned by company insiders.

HealthEquity Stock Down 1.4%

Shares of NASDAQ:HQY traded down $1.24 on Friday, reaching $89.82. The company had a trading volume of 1,284,430 shares, compared to its average volume of 918,652. HealthEquity, Inc. has a 52-week low of $73.84 and a 52-week high of $116.65. The firm's 50 day simple moving average is $96.78 and its 200-day simple moving average is $96.43. The firm has a market capitalization of $7.77 billion, a PE ratio of 65.56, a PEG ratio of 1.39 and a beta of 0.54. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.The business had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same period last year, the business posted $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. As a group, analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Barrington Research upped their target price on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, June 5th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Bank of America raised their price objective on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Raymond James Financial restated a "strong-buy" rating and set a $120.00 price objective (up from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, Royal Bank Of Canada raised their price objective on HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a report on Wednesday, June 4th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $118.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.